Leads Biolabs' Opamtistomig (PD-L1/4-1BB Bispecific Antibody) NDA Accepted by NMPA, Poised to Become World's First Approved 4-1BB-Targeting TherapyUnusual Whales·Aug 21 at 04:38 AM09887-0.14%
Nanjing Leads Biolabs says NMPA accepts NDA for LBL-024 in advanced EP-NECPUBT·Aug 21 at 03:42 AM09887-0.14%
Leads Biolabs touts promising Phase II data for NSCLC bispecific antibody LBL-024Tip Ranks·Aug 19 at 07:37 PM09887-0.14%
Nanjing Leads Biolabs says Oblenio exercises LBL-051 license option, triggering USD 10 million feePUBT·Aug 19 at 05:16 PM09887-0.14%
Nanjing Leads Biolabs schedules board meeting to review interim results, dividend recommendationPUBT·Aug 19 at 05:11 AM09887-0.14%
Nanjing Leads Biolabs Advances Key Liver Cancer Trial for OpamtistomigTip Ranks·Aug 5 at 05:30 PM09887-0.14%
Nanjing Leads Biolabs clarifies award grant to executive director is exempt connected transaction under HK rulesPUBT·Aug 4 at 06:10 AM09887-0.14%
Nanjing Leads Biolabs says China regulator clears IND for LBL-024 in metastatic colorectal cancerPUBT·Aug 2 at 05:05 PM09887-0.14%
Nanjing Leads Biolabs completes enrollment in Phase II Opamtistomig trial for advanced biliary tract cancerPUBT·Jul 30 at 04:46 AM09887-0.14%
Nanjing Leads Biolabs Co., Ltd. Class H (9887) Gets a Hold from Morgan StanleyTip Ranks·Jul 22 at 07:26 PM09887-0.14%
Hong Kong stock movement: LEADS BIOLABS-B rose 13.36%, dual antibodies received priority review and results selected for the annual meeting boost confidenceHK Stock Alerts·Jul 14 at 10:17 PM09887-0.14%
Nanjing Leads Biolabs Co., Ltd. Class H (9887) Receives a Buy from CLSATip Ranks·Jul 14 at 07:26 PM09887-0.14%RANK-1.39%
Nanjing Leads Biolabs Wins Key ESMO Slots as Flagship Immunotherapy Assets Gain MomentumTip Ranks·Jul 13 at 04:10 AM09887-0.14%
Leads Biolabs Announces Multiple Studies Selected for ESMO 2026, Highlighting the Growing Global Competitiveness of Its Core PipelineUnusual Whales·Jul 13 at 03:59 AM09887-0.14%
Nanjing Leads Biolabs says six clinical studies win presentation slots at 2026 ESMO meetingPUBT·Jul 13 at 03:37 AM09887-0.14%
